Brenda Pillari

Dr. [Last Name] is a distinguished regulatory affairs executive with over two decades of experience in the pharmaceutical and biotech industries, currently serving as Head of Regulatory Affairs, North America at Viatris, where she leads regulatory strategy and operations for the region. Prior to this role, she served as Executive Director of Regulatory Affairs at Endo Pharmaceuticals, and as Global Regulatory Affairs and Clinical Safety Director for Pharma Post-Approval CMC at Merck, where she developed and implemented CMC regulatory strategies for commercial products and managed a team of individual contributors. Her career includes serving as Sr. Director of Regulatory Affairs CMC at Pacira Pharmaceuticals, and leadership roles at Teva Pharmaceuticals, where she managed external quality and regulatory affairs for sterile drug products. She holds a Doctor of Philosophy in Environmental Science and Public Policy from George Mason University and a Master of Science in Microbiology and Pharmaceutical Marketing from Fairleigh Dickinson University. She is recognized as a strategic, collaborative, and results-driven regulatory leader who combines deep technical expertise with strong business acumen to ensure regulatory compliance, product supply continuity, and successful product life-cycle management.